indazoles has been researched along with Metaplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arbeiter, A; Baccarini, M; Dobler, M; Eser, S; Esposito, I; Gottschalk, K; Hieber, M; Kind, AJ; Klein, S; Kong, B; Messer, M; Michalski, CW; Rad, L; Rad, R; Reiff, N; Saur, D; Schlitter, AM; Schmid, RM; Schneider, G; Schnieke, AE; Seidler, B | 1 |
1 other study(ies) available for indazoles and Metaplasia
| Article | Year |
|---|---|
Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase Inhibitor p16; Enzyme Activation; Humans; Indazoles; Lithostathine; Metaplasia; Mice; Mice, Inbred NOD; Neoplasm Transplantation; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Signal Transduction; Sulfonamides; TNF Receptor-Associated Factor 3; Transplantation, Heterologous; Tumor Cells, Cultured | 2013 |